Skip to content
Open access

754. Developmental Reorganization of Network Functional Connectivity Abnormalities and Molecular Signatures in Attention-Deficit/Hyperactivity Disorder

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i65 - i66 · 0 citations

TL;DR

It is demonstrated that ADHD is characterized by developmentally FC alterations, and a key reversal in DMN-VAN connectivity between child and adult patients is identified, supporting models of delayed maturation and compensatory reorganization.

Abstract

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) manifests differently across the lifespan, yet the neurobiological mechanisms driving these changes remain inadequately understood. Aims & Objectives This meta-analysis aims to explore age-related alterations in FC in ADHD and examine the associations with transcriptomic and neurotransmitter signatures. We aim to characterize how these alterations are influenced by developmental stages and their relationship with neurochemical and molecular factors. Method Following PRISMA guidelines, we conducted a seed-based meta-analysis comparing ADHD patients (n = 4,316) and healthy controls (n = 8,709) across 43 studies. Age-stratified analyses (children, adolescents, adults) were performed to examine FC alterations within major cortical and subcortical networks. Meta-regressions were used to investigate age-related effects. Molecular associations were assessed through transcriptomic data and neurotransmitter receptor/transporter maps from publicly available databases. Results A developmentally differentiated pattern of FC alterations was observed, with the most pronounced abnormalities in childhood, partially reversing in adulthood. Within the default mode network (DMN), connectivity with the insula reversed with age, from hypoconnectivity in children to hyperconnectivity in adults. Subgroup analyses of stimulant-naïve datasets confirmed the robustness of these findings. At the molecular level, FC alterations in the sbocortical network (SCN) and DMN were spatially associated with transcriptomic pathways related to synaptic signaling, while children exhibited specific enrichment of neurodevelopmental pathways, and SCN connectivity was linked to stimulus-response-related pathways. Neurotransmitter associations were network- and age-dependent, with dopaminergic and serotonergic markers linked to cortical network changes, and noradrenergic transporter density associated with SCN dysconnectivity in children. Discussion & Conclusions We demonstrates that ADHD is characterized by developmentally FC alterations. We identify a key reversal in DMN-VAN connectivity between child and adult patients, supporting models of delayed maturation and compensatory reorganization. Crucially, the medication-naïve subgroup exhibited more extensive DMN dysconnectivity, suggesting that pharmacological treatment may partially mask intrinsic network deficits. By integrating FC with transcriptomic and neurochemical evidence, we further reveal that these network-level abnormalities are associated with distinct molecular and neuromodulatory mechanisms that vary across networks and developmental stages. Together, these findings advance a multi-system framework for understanding ADHD from childhood to adulthood, bridging macro-scale network dysfunction with meso-scale biological substrates, and offering novel insights for intervention targets.

Read PDF

Similar papers

Open access Sep 2026

Brain network localization of gray matter alterations and executive dysfunction in pediatric ADHD.

BACKGROUND Attention-deficit/hyperactivity disorder (ADHD) is characterized by gray matter alterations and executive dysfunction. Whether the spatially distributed regional abnormalities reported in previous meta-analyses converge within large-scale networks of the developing brain remains unclear. Using coordinate-inf...

Ye-Xian Zeng, Jia Cheng, Ming-Rui Xia et al. · 0 citations
Open access Sep 2026

145. Cortical thinning and hippocampal expansion as brain signatures of ADHD symptom trajectories

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) affects around 5% of children and adolescents world-wide and is characterized by its significant clinical heterogeneity, including different symptom courses, such as persistent, remitting, and emergent trajectories during adolescence and adulthood, whi...

W. Hou, B. Sahakian, S. Cortese et al. · 0 citations
Oct 2026

Connection-Level Multi-Omics Reveals Cerebellar-Cortical Dysconnectivity and Divergent Molecular Signatures Across Major Psychiatric Disorders.

BACKGROUND Understanding how disease-related connectome alterations relate to underlying molecular systems remains a major challenge in psychiatric disorders. METHODS Here we introduce BrainNetAnno (https://brainnetanno.readthedocs.io/en/latest), an open-source framework for molecular annotation of brain network conn...

Yun-Heng Diao, Yuan-Yuan Huang, Bao-Yuan Zhu et al. · 0 citations
Open access Sep 2026

666. ADHD: genes and risk for other conditions

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder characterized by substantial clinical heterogeneity and frequent comorbidity with sleep disturbances, inflammatory conditions, and metabolic dysregulation. While ADHD has traditionally been conceptualiz...

N. Takahashi · 0 citations
Open access Sep 2026

41. Longitudinal analysis of ADHD across development in DAT Val559-KI mice

This study integrates longitudinal behavioral, pharmacological, and neurochemical analyses in a humanized ADHD mouse model, addressing key gaps in adult ADHD research and supports refinement of diagnostic criteria and the development of tailored interventions across the lifespan.

R. J. Custodio, E. Wascher, S. Getzmann · 0 citations
Open access Sep 2026

428. ADHD: neurocognitive pathways

Abstract Background ADHD is characterized by its clinical heterogeneity in symptoms and their trajectories. However, both cognitive impairment and motivational dysfunction in the well-known ‘dual-pathway model for ADHD’ can be absent in about 30% of ADHD cases and cannot predict the persistence or remitting of the symp...

Q. Luo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.